Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 74.58 USD Market Closed
Market Cap: 5.3B USD

Intrinsic Value

The intrinsic value of one ZLDPF stock under the Base Case scenario is 119.65 USD. Compared to the current market price of 74.58 USD, Zealand Pharma A/S is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZLDPF Intrinsic Value
119.65 USD
Undervaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Zealand Pharma A/S

What is Valuation History?
Ask AI Assistant
What other research platforms think about ZLDPF?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ZLDPF valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Zealand Pharma A/S.

Explain Valuation
Compare ZLDPF to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ZEAL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zealand Pharma A/S

Current Assets 16.6B
Cash & Short-Term Investments 16.2B
Receivables 224.7m
Other Current Assets 226.9m
Non-Current Assets 176.2m
PP&E 141.4m
Intangibles 12.7m
Other Non-Current Assets 22.1m
Current Liabilities 1.2B
Accounts Payable 243.9m
Other Current Liabilities 934.7m
Non-Current Liabilities 456.1m
Long-Term Debt 383.9m
Other Non-Current Liabilities 72.2m
Efficiency

Free Cash Flow Analysis
Zealand Pharma A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zealand Pharma A/S

Revenue
9.2B DKK
Cost of Revenue
-1.2m DKK
Gross Profit
9.2B DKK
Operating Expenses
-1.9B DKK
Operating Income
7.3B DKK
Other Expenses
-724.1m DKK
Net Income
6.5B DKK
Fundamental Scores

ZLDPF Profitability Score
Profitability Due Diligence

Zealand Pharma A/S's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional ROE
Exceptional Operating Margin
ROIC is Increasing
56/100
Profitability
Score

Zealand Pharma A/S's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

ZLDPF Solvency Score
Solvency Due Diligence

Zealand Pharma A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Zealand Pharma A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 117.81 USD with a low forecast of 62.13 USD and a high forecast of 180.84 USD.

Lowest
Price Target
62.13 USD
17% Downside
Average
Price Target
117.81 USD
58% Upside
Highest
Price Target
180.84 USD
142% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Zealand Pharma A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for ZEAL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

ZLDPF News

Other Videos
What is the Intrinsic Value of one ZLDPF stock?

The intrinsic value of one ZLDPF stock under the Base Case scenario is 119.65 USD.

Is ZLDPF stock undervalued or overvalued?

Compared to the current market price of 74.58 USD, Zealand Pharma A/S is Undervalued by 38%.

Back to Top